PubRank

Howard Minkoff

Author PubWeight™ 147.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005 5.29
2 The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann Intern Med 2004 3.05
3 Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003 2.81
4 Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004 2.23
5 Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 2006 2.19
6 Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007 2.11
7 Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002 2.11
8 Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005 2.04
9 Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 2010 2.00
10 The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. J Acquir Immune Defic Syndr 2005 1.96
11 Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS 2004 1.94
12 Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol 2014 1.88
13 Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005 1.86
14 Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 2003 1.78
15 HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Natl Acad Sci U S A 2003 1.71
16 Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis 2011 1.70
17 Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 2011 1.68
18 Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis 2002 1.59
19 Changes in sexual behavior among HIV-infected women after initiation of HAART. Am J Public Health 2004 1.59
20 Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 2003 1.57
21 The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica 2006 1.53
22 Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res 2004 1.50
23 Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy. Am J Obstet Gynecol 2007 1.48
24 Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol 2006 1.46
25 Methicillin-resistant Staphylococcus aureus necrotizing pneumonia arising from an infected episiotomy site. Obstet Gynecol 2007 1.46
26 Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV. AIDS 2016 1.45
27 Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer 2009 1.42
28 Challenging the strategy of maternal age-based prenatal genetic counseling. JAMA 2006 1.41
29 Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis 2007 1.37
30 Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2002 1.35
31 C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr 2003 1.35
32 Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2005 1.31
33 Obesity and immune cell counts in women. Metabolism 2007 1.31
34 Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 2004 1.30
35 CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. J Infect Dis 2003 1.29
36 Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 2010 1.28
37 The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study. J Acquir Immune Defic Syndr 2006 1.24
38 Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. AIDS 2004 1.21
39 Contraceptive use among U.S. women with HIV. J Womens Health (Larchmt) 2007 1.20
40 Depressive symptoms in the immediate postpartum period among Hispanic women in three U.S. cities. J Immigr Health 2004 1.19
41 Effect of clinical-decision support on documentation compliance in an electronic medical record. Obstet Gynecol 2009 1.14
42 The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis 2011 1.13
43 Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 2009 1.12
44 Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS 2006 1.11
45 Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women. J Acquir Immune Defic Syndr 2009 1.10
46 HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol 2010 1.09
47 Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women. AIDS 2014 1.06
48 Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. Am J Epidemiol 2005 1.06
49 Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA 2012 1.06
50 Maternal-infant perinatal transmission of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Am J Perinatol 2008 1.04
51 Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding. J Acquir Immune Defic Syndr 2012 1.03
52 Relative time to pregnancy among HIV-infected and uninfected women in the Women's Interagency HIV Study, 2002-2009. AIDS 2011 1.02
53 Determinants of women's choice of obstetrician/gynecologist. J Womens Health Gend Based Med 2002 1.01
54 Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS 2003 1.00
55 Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol 2005 1.00
56 Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril 2008 0.99
57 HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance. J Womens Health (Larchmt) 2004 0.99
58 Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. Am J Pathol 2002 0.97
59 In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus. Biol Psychiatry 2004 0.97
60 Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data. Virol J 2010 0.96
61 Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. J Womens Health (Larchmt) 2006 0.96
62 Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertil Steril 2012 0.96
63 Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women. J Acquir Immune Defic Syndr 2013 0.94
64 Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol 2011 0.94
65 HIV tropism and decreased risk of breast cancer. PLoS One 2010 0.94
66 Relationship between HIV viral load and Langerhans cells of the cervical epithelium. J Obstet Gynaecol Res 2005 0.94
67 The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis 2002 0.93
68 Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS 2013 0.93
69 Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol 2006 0.93
70 Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus. Obstet Gynecol 2004 0.92
71 Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. AIDS Res Hum Retroviruses 2009 0.92
72 Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer. J Acquir Immune Defic Syndr 2014 0.91
73 Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women's Interagency HIV Study. AIDS 2007 0.91
74 Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy. J Virol 2011 0.91
75 Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women. Hepatology 2012 0.91
76 Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS). Hum Immunol 2007 0.91
77 Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer. Oncologist 2012 0.90
78 A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection. Sex Transm Dis 2015 0.89
79 Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women. Fertil Steril 2007 0.89
80 Long-term cumulative detection of human papillomavirus among HIV seropositive women. AIDS 2014 0.88
81 Incidence and risk factors for verrucae in women. AIDS 2008 0.88
82 Insulin-like growth factor axis and oncogenic human papillomavirus natural history. Cancer Epidemiol Biomarkers Prev 2008 0.88
83 Use of prenatal care by Hispanic women after welfare reform. Obstet Gynecol 2006 0.86
84 Changes in cervical length and the risk of preterm labor. Am J Obstet Gynecol 2002 0.85
85 Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women. AIDS 2007 0.85
86 Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus. Am J Obstet Gynecol 2003 0.85
87 Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women. J Infect Dis 2008 0.85
88 Aging and HIV infection. J Urban Health 2006 0.85
89 Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study. AIDS Res Ther 2013 0.84
90 Rapid HIV screening for women in labor. Expert Rev Mol Diagn 2005 0.84
91 Plasma brain-derived neurotrophic factor in women after bariatric surgery: a pilot study. Fertil Steril 2008 0.84
92 Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia. Obstet Gynecol 2012 0.83
93 Improved obstetric safety through programmatic collaboration. J Healthc Risk Manag 2014 0.83
94 Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab 2014 0.82
95 Cervicovaginal human papillomavirus (HPV)-infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women. Int J Cancer 2012 0.82
96 Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers. PLoS One 2010 0.82
97 Relationship of bariatric surgery to Müllerian-inhibiting substance levels. Fertil Steril 2007 0.82
98 Effect of bariatric surgery on peripheral blood lymphocyte subsets in women. Surg Obes Relat Dis 2008 0.82
99 Negative predictive value of pap testing: implications for screening intervals for women with human immunodeficiency virus. Obstet Gynecol 2012 0.82
100 Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection. J Acquir Immune Defic Syndr 2009 0.81
101 Effect of stress and depression on the frequency of squamous intraepithelial lesions. J Low Genit Tract Dis 2011 0.81
102 Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. AIDS Res Hum Retroviruses 2008 0.80
103 CCR2 genotype and disease progression in a treated population of HIV type 1-infected women. Clin Infect Dis 2004 0.79
104 High-grade cervical disease in adolescents with HIV. J Low Genit Tract Dis 2008 0.79
105 Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability. AIDS 2011 0.79
106 Comparison of serum and plasma measurements of Müllerian inhibiting substance. Fertil Steril 2007 0.79
107 Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2003 0.78
108 Abnormal pap tests and human papillomavirus infections among HIV-infected and uninfected women who have sex with women. J Low Genit Tract Dis 2014 0.78
109 Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study. J Neurovirol 2013 0.78
110 The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women. Viral Immunol 2014 0.78
111 The relationship of praise/criticism to learning during obstetrical simulation: a randomized clinical trial. J Perinat Med 2014 0.78
112 Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. Obstet Gynecol 2011 0.78
113 Ovarian hyperstimulation syndrome after a molar pregnancy evacuation. Fertil Steril 2008 0.77
114 Systemic Immune Activation and HIV Shedding in the Female Genital Tract. J Acquir Immune Defic Syndr 2016 0.77
115 The role of covering gowns in reducing rates of bacterial contamination of scrub suits. Am J Obstet Gynecol 2003 0.77
116 Obstetricians, health attorneys, and court-ordered cesarean sections. Womens Health Issues 2007 0.77
117 Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristics. J Acquir Immune Defic Syndr 2012 0.76
118 Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women. Fertil Steril 2011 0.76
119 Ethical issues with vaccination for the obstetrician-gynecologist. Obstet Gynecol 2014 0.76
120 Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative women. Cancer Epidemiol Biomarkers Prev 2010 0.76
121 Tamoxifen and growth of an extrauterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 2008 0.76
122 Ethical considerations in elective cesarean delivery. Clin Obstet Gynecol 2004 0.75
123 Risk of breast cancer with CXCR4-using HIV defined by V3 loop sequencing. J Acquir Immune Defic Syndr 2015 0.75
124 Novel influenza H1N1 in pregnancy: a report of two cases. Infect Dis Obstet Gynecol 2010 0.75
125 Multitype Infections With Human Papillomavirus: Impact of Human Immunodeficiency Virus Coinfection. Sex Transm Dis 2016 0.75
126 The Relationship between Tests of Neurocognition and Performance on a Laparoscopic Simulator. Minim Invasive Surg 2010 0.75
127 Presumed cases of mumps in pregnancy: clinical and infection control implications. Infect Dis Obstet Gynecol 2012 0.75
128 Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus. Obstet Gynecol 2009 0.75
129 Knowledge of ovarian reserve and reproductive choices. J Assist Reprod Genet 2015 0.75
130 Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection. Int J Cancer 2013 0.75
131 For whom the bell tolls. Am J Obstet Gynecol 2007 0.75
132 A Call for Change in a Changing World. Obstet Gynecol 2016 0.75
133 Uterine rupture among women with a prior cesarean delivery. N Engl J Med 2002 0.75
134 Alpha-fetoprotein as a tool to distinguish amniotic fluid from urine, vaginal discharge, and semen. Obstet Gynecol 2015 0.75
135 A Sanitary Pad for Self-Assessment of Rupture of Membranes. Obstet Gynecol 2016 0.75
136 High sensitivity C-reactive protein and response to highly active antiretroviral therapy in women with HIV-1 infection. J Acquir Immune Defic Syndr 2006 0.75
137 Human Metapneumovirus Infection and Acute Respiratory Distress Syndrome During Pregnancy. Obstet Gynecol 2017 0.75
138 Home birth: what are physicians' ethical obligations when patient choices may carry increased risk? Obstet Gynecol 2011 0.75
139 Neonatal Abstinence Syndrome and Ethical Approaches to the Identification of Pregnant Women Who Use Drugs. Obstet Gynecol 2016 0.75
140 Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS 2017 0.75
141 Consensus report on the detailed fetal anatomic ultrasound examination: indications, components, and qualifications. J Ultrasound Med 2014 0.75
142 Vesicovaginal fistula associated with cytomegalovirus infection in an HIV-infected patient. Gynecol Obstet Invest 2006 0.75
143 Fetal protection and women's access to clinical trials. J Womens Health 1992 0.75